Sylviane Olschwang

Summary

Country: France

Publications

  1. pmc SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
    Guillaume Rousseau
    Laboratory of Molecular Oncogenetics, Institut Paoli Calmettes, Marseille, France
    BMC Neurol 11:9. 2011
  2. doi request reprint [Early-onset colorectal carcinoma study]
    Janick Selves
    J Selves Inserm U563, CPTP, CHU Purpan, BP 3028, 31024 Toulouse Cedex 3
    Med Sci (Paris) 25:25-8. 2009
  3. pmc The LKB1 complex-AMPK pathway: the tree that hides the forest
    Michael Sebbagh
    INSERM, U891, Centre de Recherche en Cancerologie de Marseille, 27 Blv Lei Roure, 13009, Marseille, France
    Fam Cancer 10:415-24. 2011
  4. doi request reprint Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP
    Arnaud Lagarde
    Centre de Recherche en Cancérologie de Marseille INSERM UMR891, Marseille, France
    J Med Genet 47:721-2. 2010
  5. ncbi request reprint BRAF p.Val600Glu (V600E) somatic mutation is mainly associated with MSS phenotype in metastatic colorectal cancer
    Jinghua Qiu
    Institut Paoli Calmettes, Marseille, France
    Cancer Genomics Proteomics 8:15-8. 2011

Collaborators

  • Anthony Goncalves
  • Etienne Rouleau
  • Daniel Birnbaum
  • Janick Selves
  • Jinghua Qiu
  • Arnaud Lagarde
  • Michael Sebbagh
  • Guillaume Rousseau
  • Violaine Bourdon
  • Tetsuro Noguchi
  • Hagay Sobol
  • Jean Paul Borg
  • Olivier Turrini
  • Marion Compagnone
  • Sophy Laibe
  • Marie Josée Santoni
  • Genevieve Monges
  • Luc Xerri
  • José Adélaïde
  • Anthony Ferrari
  • Rosette Lidereau
  • Pascaline Gaildrat
  • Virginie Remy
  • Adrien Briaux

Detail Information

Publications5

  1. pmc SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
    Guillaume Rousseau
    Laboratory of Molecular Oncogenetics, Institut Paoli Calmettes, Marseille, France
    BMC Neurol 11:9. 2011
    ..In contrast, germline mutations of the SMARCB1 (INI1) tumor suppressor gene were described in familial and sporadic schwannomatosis patients...
  2. doi request reprint [Early-onset colorectal carcinoma study]
    Janick Selves
    J Selves Inserm U563, CPTP, CHU Purpan, BP 3028, 31024 Toulouse Cedex 3
    Med Sci (Paris) 25:25-8. 2009
    ..The next step will consist in validating a molecular signature specific for early-onset carcinoma. Genomic profile does not differ from that observed in late-onset colon cancers...
  3. pmc The LKB1 complex-AMPK pathway: the tree that hides the forest
    Michael Sebbagh
    INSERM, U891, Centre de Recherche en Cancerologie de Marseille, 27 Blv Lei Roure, 13009, Marseille, France
    Fam Cancer 10:415-24. 2011
    ..This review will discuss about LKB1 activity regulation, its effectors and clues on their involvement in cell polarity...
  4. doi request reprint Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP
    Arnaud Lagarde
    Centre de Recherche en Cancérologie de Marseille INSERM UMR891, Marseille, France
    J Med Genet 47:721-2. 2010
    ..The work presented here delineates precisely the APC mutation spectrum from 15 years of systematic molecular screening which identified 863 independent alterations in the French population...
  5. ncbi request reprint BRAF p.Val600Glu (V600E) somatic mutation is mainly associated with MSS phenotype in metastatic colorectal cancer
    Jinghua Qiu
    Institut Paoli Calmettes, Marseille, France
    Cancer Genomics Proteomics 8:15-8. 2011
    ..The impact of BRAF V600E mutation is not well documented...